drugset / Trial / NCT01377571

A Dose-escalating Study to Evaluate the Immunogenicity and Safety of Rotavin-M1 Vaccine in Healthy Infants

NCT01377571

RandomizedParallel-groupQuadruple-blind

Summary

The purpose of this study is to evaluate the safety and immunogenicity of Rotavin-M1 produced by the Center for Research and Production of Vaccines and Biologicals (POLYVAC) in infants in Vietnam. In addition, we evaluate different dosages and schedules to determine the best regimen to test in a clinical trial.

Timeline

Start
2009-10
Primary completion
2010-03
Completion
2010-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Rotarix Vaccine 106.5 unknown

Indications